Clinical trial
Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
NCT05605236 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 16, 2020
- Completion date
- July 16, 2022
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bronchial cancer